The University of Chicago Header Logo

Connection

Jessica J. Kandel to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Jessica J. Kandel has written about Drug Administration Schedule.
Jessica J. Kandel
Connection Strength
0.074
Drug Administration Schedule
  1. Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor. J Pediatr Surg. 2001 Dec; 36(12):1781-4.
    View in: PubMed
    Score: 0.044
  2. Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series. Pediatrics. 2016 09; 138(3).
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.